Valuation Genus plc OTC Markets

Stocks

Market Closed - OTC Markets 12:40:14 2026-05-13 EDT			5-day change	1st Jan Change
31.06 ^USD	+0.29%		-.--%	-11.24%

09-10	Europe mixed before ECB as US yields surge	AN
09-10	Genus lifts dividend, starts GBP60 million share buyback as profit up	AN

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,221	1,634	1,417	1,082	1,343	1,447	-	-
Change	-	-49.26%	-13.32%	-23.64%	24.18%	7.69%	-	-
Enterprise Value (EV) ¹	3,327	1,819	1,612	1,331	1,572	1,509	1,511	1,477
Change	-	-45.31%	-11.38%	-17.49%	18.12%	-3.97%	-1.9%	-2.23%
P/E	68.9x	40.3x	42.9x	139x	70.8x	5.05x	23.9x	21.7x
PBR	6.48x	2.84x	2.47x	1.98x	2.83x	1.85x	2.01x	1.92x
PEG	-	-3x	-2.3x	-1.8x	0x	0x	-0.5x	2.1x
Capitalization / Revenue	5.61x	2.75x	2.05x	1.62x	2x	2.18x	2.13x	2.09x
EV / Revenue	5.79x	3.07x	2.34x	1.99x	2.34x	2.29x	2.22x	2.13x
EV / EBITDA	31.5x	18.2x	14.6x	12.2x	13.1x	11.5x	10.6x	10.9x
EV / EBIT	43.3x	26.4x	21.6x	19.9x	19.4x	15.9x	17.5x	15.5x
EV / FCF	85.7x	-233x	88.6x	42.8x	32.3x	22.4x	25.2x	21.4x
FCF Yield	1.17%	-0.43%	1.13%	2.34%	3.09%	4.47%	3.98%	4.68%
Dividend per Share ²	0.32	0.32	0.32	0.32	0.32	0.352	0.3584	0.3829
Rate of return	0.65%	1.28%	1.48%	1.94%	1.56%	1.64%	1.66%	1.77%
EPS ²	0.72	0.622	0.505	0.119	0.289	4.251	0.905	0.9986
Distribution rate	44.4%	51.4%	63.4%	269%	111%	8.28%	39.6%	38.3%
Net sales ¹	574.3	593.4	689.7	668.8	672.8	658.1	680.7	693.8
EBITDA ¹	105.5	99.9	110.6	108.9	119.8	130.9	142.7	135.7
EBIT ¹	76.9	68.8	74.6	67	81.1	94.8	86.45	95.36
Net income ¹	47.3	40.9	33.3	7.9	19.3	285.3	57.13	64.68
Net Debt ¹	105.6	185	195.8	248.7	228.2	71.8	64.03	30.35
Reference price ²	49.60	25.08	21.66	16.50	20.45	21.62	21.62	21.62
Nbr of stocks (in thousands)	64,941	65,168	65,404	65,564	65,692	66,916	-	-
Announcement Date	9/9/21	9/8/22	9/7/23	9/5/24	9/4/25	9/10/26	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	31.04x	5.6x	16.76x	1.05%	45.48B
REVOLUTION MEDICINES, INC.	-20.85x	240.83x	-22.36x	-.--%	43.69B
IQVIA HOLDINGS INC.	33.71x	3.27x	14.1x	-.--%	43.09B
BEONE MEDICINES AG	45.39x	5.23x	28.64x	-.--%	39.4B
CELLTRION, INC.	27.03x	8.15x	20.66x	0.42%	31.91B
MEDPACE HOLDINGS, INC.	33.41x	5.47x	24.85x	-.--%	16.4B
EUROFINS SCIENTIFIC SE	23.57x	2.06x	8.94x	1.13%	14.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.44x	3.94x	15.27x	-.--%	13.28B
Average	30.97x	34.32x	13.36x	0.33%	30.94B
Weighted average by Cap.	26.17x	46.69x	11.79x	0.31%